Skip to main content

Table 3 Summary of the JAK2 genotype in MPN patients

From: The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population

  GCC genotype non-GCC genotype P(Chi-square test) Odds ratio 95% CI
Case Population 46/1 haplotype rs4495987(+) non-46/1 haplotype rs4495987(-)    
JAK2V617F-positive PV (n = 33) 22 11 0.0023 3.63 1.59-8.29
JAK2V617F-positive ET (n = 57) 35 22 0.0043 2.72 1.40-5.32
JAK2V617F-negative ET (n = 39) 24 15 0.0076 2.91 1.36-6.19
JAK2V617F-positive MPN (n = 95) 60 35 0.0001 3.07 1.73-5.46
JAK2V617F-negative MPN (n = 43) 24 19 0.0289 2.26 1.01-4.70
Control: non-MPN (n = 107) 38 69